Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZY021 vs Xiongdan Jiaonang for acute pharyngitis
CTR20212380Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZY021 in acute pharyngitis, sponsored by Shanghai Institute of Materia Medica. Started Sep 2021; status: completed.
02
Drugs
ZY021
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on CTR20212380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212380.